x̄ - > Study: Unemployed, uninsured less likely to receive cancer screening

Researchers say that unemployed, uninsured people are less likely to undergo routine cancer screenings -- and that these gaps decrease their long-term likelihood of staying up-to-date on routine screenings. 
Nov. 8 (UPI) -- Unemployed adults in the United States are less likely to undergo recommended cancer screening because they lack health insurance, a survey published Monday by the journal Cancer found.
More than 40% of responding adults who were unemployed reported that they did not have health insurance, compared with just 10% of those who had a job, the data showed.
Compared with those who were employed at the time of the study, fewer unemployed adults indicated they were up-to-date on recommended screening for breast, cervical, colorectal, and prostate cancers.
For example, 68% of unemployed adults had been screened for breast cancer versus 78% of those currently working, according to the researchers.
And, screening rates for colorectal cancers, including colon cancer, were lower among the unemployed, at 42%, than the employed, at 49%.
"People who were unemployed at the time of the survey were less likely to have a recent cancer screening test and they were also less likely to be up-to-date with their cancer screenings over the long term," study co-author Stacey Fedewa said in a press release.
"This suggests that being unemployed at a single point in time may hinder both recent and potentially longer-term screening practices," said Fedewa, a senior principal scientist at the American Cancer Society.
Not undergoing routine screening for cancer can increase a person's risk of being diagnosed with late-stage cancer, which is more difficult to treat than cancer that is detected at an early stage.
About 30 million people in the United States do not have health insurance, the Department of Health and Human Services estimates.
Screening guidelines differ by type of cancer.
For example, the Centers for Disease Control and Prevention recommends that adults undergo screening for colon cancer, via colonoscopy, starting between age 45 and 50.
It also advises women to get screened for cervical cancer every three years, starting in their 20s, while they should undergo mammograms between ages 50 and 74.
Prostate cancer screening recommendations are less clear.
For this study, Fedewa and her colleagues analyzed information from adults under age 65 who responded to the 2000-2018 National Health Interview Survey, a nationally representative annual survey of the United States population on health and insurance status.
Among the unemployed, 79% had been screened for cervical cancer, compared with 86% of those currently working, the data showed.
Similarly, 25% of the unemployed said they had been screened for prostate cancer, while 36% of the employed had done so.
All differences in cancer screening rates were eliminated after the researchers accounted for health insurance coverage, highlighting the importance of insurance coverage for enabling individuals to receive recommended cancer screening tests, they said.
"Our finding that insurance coverage fully accounted for unemployed adults' lower cancer screening utilization is potentially good news because it's modifiable," Fedewa said.
"When people are unemployed and have health insurance, they have screening rates that are similar to employed adults," she said.

x̄ - > The limit theorem with R programming

Introduction to Limit Theorems

The limit theorem refers to a fundamental concept in mathematics and statistics that describes the behavior of a sequence of random variables or the sum of a large number of independent and identically distributed random variables. There are several types of limit theorems, but the most well-known ones are the law of large numbers and the central limit theorem.

1. Law of Large Numbers

The law of large numbers states that as the number of independent and identically distributed random variables increases, their average (or sum) converges to the expected value of the random variable. In simpler terms, it suggests that if you repeat an experiment a large number of times, the average outcome will approach the true expected value.

2. Central Limit Theorem

The central limit theorem states that the sum or average of a large number of independent and identically distributed random variables will be approximately normally distributed, regardless of the shape of the original distribution. This theorem is particularly important because it enables the use of statistical techniques that assume a normal distribution, even when the underlying variables may not be normally distributed themselves.

These limit theorems are crucial in probability theory and statistics as they provide a theoretical foundation for many statistical methods and allow us to make inferences about populations based on sample data.

Demonstrating the Law of Large Numbers in R

Below, we'll simulate rolling a fair six-sided die and calculate the average value as we roll it more and more times.

# Number of die rolls
num_rolls <- 1000

# Simulating die rolls
rolls <- sample(1:6, num_rolls, replace = TRUE)

# Calculate the cumulative average
cumulative_average <- cumsum(rolls) / (1:num_rolls)

# Plot the cumulative average
plot(1:num_rolls, cumulative_average, type = "l", xlab = "Number of Rolls", ylab = "Average")

# Add a horizontal line at the expected value (3.5 for a fair die)
abline(h = 3.5, col = "red")

In this code, we start by specifying the number of rolls (num_rolls). We then simulate rolling a fair die num_rolls times using the sample function. The cumulative_average variable calculates the cumulative average of the rolls up to each roll number.

Finally, we plot the cumulative average against the number of rolls using plot. We also add a horizontal line at the expected value of 3.5, representing the true expected value for a fair six-sided die.

If you run this code, you'll observe that as the number of rolls increases, the cumulative average will converge towards the expected value of 3.5, demonstrating the Law of Large Numbers.

Demonstrating the Central Limit Theorem in R

In this case, we'll simulate the sum of a large number of random variables drawn from a non-normal distribution (exponential distribution) and observe the resulting distribution.

# Number of random variables to sum
num_variables <- 1000

# Number of simulations
num_simulations <- 10000

# Simulating exponential random variables
simulations <- replicate(num_simulations, sum(rexp(num_variables)))

# Plotting the histogram of the simulation results
hist(simulations, breaks = 30, prob = TRUE, col = "lightblue", main = "Sum of Exponential Random Variables")

In this code, we first specify the number of random variables to sum (num_variables) and the number of simulations (num_simulations). We then use the replicate function to generate num_simulations samples of the sum of num_variables exponential random variables using the rexp function.

Finally, we plot the histogram of the simulation results using hist. The resulting histogram will approximate a bell-shaped, approximately normal distribution, illustrating the Central Limit Theorem.

Keep in mind that the Central Limit Theorem is an asymptotic result, meaning that it holds as the number of random variables approaches infinity. In practice, even with a moderately large number of variables, you can observe the approximation to a normal distribution.

x̄ - > Cytotoxicity Analysis Report

Cytotoxicity Analysis Report

Summary

This report presents the results of the cytotoxicity assay analysis for various treatments: T. vogelii, Pentostam, Amphotericin B, and an RPMI control framework. The analysis includes dose-response evaluations, statistical comparisons via one-way ANOVA with subsequent Tukey's HSD post-hoc tracking tests, and data distributions structured through informational box plot visualizations.

Dose-Response Curves

Dose-response curves were mapped out for each therapeutic treatment to isolate explicit IC₅₀ indices (representing the metric boundary concentration at which 50% of the maximum cytotoxic footprint is observed).

1. T. vogelii: IC₅₀ ≈ 5.0
2. Pentostam: IC₅₀ ≈ 5.0
3. Amphotericin B: IC₅₀ ≈ 4.0

Interpretation: Amphotericin B exhibits the highest potency threshold within this profile, followed subsequently by T. vogelii and Pentostam, which display matching potency distributions.

Statistical Comparison

A one-way ANOVA profile evaluation was performed to quantify structural cytotoxicity variations across treatment environments. The metrics highlighted distinct mathematical configuration changes across boundaries (p < 0.05).

ANOVA Results:

• Sum of Squares (Treatment): 754,456.3
• Degrees of Freedom (Treatment): 3
• F-statistic: 4.987
• p-value: 0.004941

Interpretation: There are highly statistically significant variances in isolated cytotoxicity tracking outputs across the distinct treatment metrics evaluated.

Tukey's HSD Post-Hoc Test Results

The Tukey's Honest Significant Difference (HSD) test pinpointed which paired testing models cross explicit classification significance lines.

Significant Pairings:

• Amphotericin B vs RPMI: Significant (p < 0.05)
• Pentostam vs RPMI: Significant (p < 0.05)
• RPMI vs T. vogelii: Significant (p < 0.05)

Non-Significant Pairings:

• Amphotericin B vs Pentostam
• Amphotericin B vs T. vogelii
• Pentostam vs T. vogelii

Interpretation: Amphotericin B, Pentostam, and T. vogelii generate a highly unique cytotoxicity deviation envelope relative to the baseline RPMI control frame but remain statically indistinguishable from one another.

Box Plot Visualization

The structured chart model maps the concentration variance spread configurations across all corresponding experimental cells.

• RPMI Control: Cytotoxicity values maintain a flat, baseline horizontal distribution ceiling across all tested concentrations.
• Amphotericin B: Manifests the lowest median tracking cytotoxicity metric footprint at high dosage concentrations.
• Pentostam and T. vogelii: Display similar distribution patterns characterized by declining cytotoxicity traces as dosage profiles decrease.

Visualizations

Recommendations

1. Time-Dependent Cytotoxicity: Assess how cytotoxicity profiles adjust across specific execution durations at stationary density levels.
2. Mechanism of Action Study: Track down and isolate the specific intracellular signaling channels triggering target cellular destruction.
3. Combination Therapy Analysis: Evaluate compound mixture matrices to verify if co-administration yields beneficial synergetic effects.
4. Longitudinal Study: Design elongated analytical tracking horizons to verify extended exposure behaviors.
5. Dose-Response Relationship in Different Cell Lines: Cross-examine compound impacts against alternate diagnostic cell frameworks to verify target profiling consistency.

Conclusion

This comprehensive critique successfully benchmarks the comparative cytotoxicity metrics of T. vogelii, Pentostam, and Amphotericin B. While all experimental treatments varied significantly from the target environment control framework, Amphotericin B displayed the most clear therapeutic efficacy margin. Adopting follow-up research projects focusing on molecular dynamics and cross-cell line scaling properties will enrich this analytical footprint.

This work is licensed under a Creative Commons Attribution 4.0 International License.

x̄ - > Introduction to Linear Algebra

Linear algebra is something all mathematics undergraduates and many other students, in subjects ranging from engineering to economics, have to learn. The fifth edition of this hugely successful textbook retains the quality of earlier editions while at the same time seeing numerous minor improvements and major additions. The latter includes a new chapter on singular values and singular vectors, including ways to analyze a matrix of data; a revised chapter on computing in linear algebra, with professional-level algorithms and code that can be downloaded for a variety of languages; a new section on linear algebra and cryptography; and a new chapter on linear algebra in probability and statistics. A dedicated and active website also offers solutions to exercises as well as new exercises from many different sources (e.g. practice problems, exams, development of textbook examples), plus codes in MATLAB, Julia, and Python. This fifth edition contains numerous minor improvements and major additions Provides a new chapter on singular values and singular vectors, as well as a revised chapter on computing in linear algebra A dedicated and active website offers solutions to exercises, new exercises from several sources, and codes in MATLAB, Julia, and Python Read more Customer reviews Not yet reviewed Be the first to review Review was not posted due to profanity × Product details Edition: 5th Edition Date Published: June 2021 format: Hardback ISBN: 9781733146654 length: 584 pages dimensions: 242 x 198 x 31 mm weight: 1.17kg availability: In stock Table of Contents 1. Introduction to vectors2. Solving linear equations3. Vector spaces and subspaces4. Orthogonality5. Determinants6. Eigenvalues and eigenvectors7. The singular value decomposition (SVD)8. Linear transformations9. Complex vectors and matrices10. Applications11. Numerical linear algebra12. Linear algebra in probability and statisticsMatrix factorizationsIndexSix great theorems/linear algebra in a nutshell. Author Gilbert Strang, Massachusetts Institute of TechnologyGilbert Strang is a professor of mathematics at the Massachusetts Institute of Technology, where his research focuses on analysis, linear algebra and PDEs. He is the author of many textbooks and his service to the mathematics community is extensive. He has spent time both as President of SIAM and as Chair of the Joint Policy Board for Mathematics, and has been a member of various other committees and boards. He has received several awards for his research and teaching, including the Chauvenet Prize (1976), the Award for Distinguished Service (SIAM, 2003), the Graduate School Teaching Award (Massachusetts Institute of Technology, 2003) and the Von Neumann Prize Medal (US Association for Computational Mechanics, 2005), among others. He is a Member of the National Academy of Sciences, a Fellow of the American Academy of Arts and Sciences, and an Honorary Fellow of Balliol College, Oxford.